VDyne Tricuspid Valve
Expanding Patient Access to Minimally-Invasive Tricuspid Valve Replacement
The VDyne Valve System is an investigational product only that is presently undertaking human (clinical) feasibility studies. The VDyne System is not approved for sale or use for the treatment of any health condition.
Expands Treatable Patient Population
-
Minimizes structural exclusions through unique transfemoral side-delivery and shallow entry to annulus placement
-
Accommodates low right atrium (RA) height, right ventricle (RV) structures, and previously implanted devices such as leads
-
Available in five sizes, allowing treatment of a wide range of patients
The Only Tricuspid Valve Replacement System That Optimizes Positioning
-
Ability to fully evaluate function prior to valve release
-
Repositionable and retrievable – no hooks or barbs used
-
Designed to match the asymmetric tricuspid anatomy enabling atraumatic self-alignment
Reduces Imaging Burden Associated With Current Valve Replacement Procedures
-
Dual imaging modality minimizes echo imaging challenges and increases efficiency
-
More efficient procedures benefit physicians and patients
THE VDYNE VALVE
Designed to conform to the patient's tricuspid anatomy, our proprietary side-delivery technology supports a wide range of valve sizes to treat more patients in need. The VDyne Valve's unique shallow delivery trajectory and self-aligning design simplifies the implantation and reduces the imaging burden of today's procedures.
THE VDYNE PROCEDURE
